Parametric Portfolio Associates’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-38,005
Closed -$6.57M 4075
2015
Q1
$6.57M Buy
38,005
+4,178
+12% +$613K 0.01% 1074
2014
Q4
$3.89M Sell
33,827
-12,193
-26% -$1.48M 0.01% 1489
2014
Q3
$7.19M Buy
46,020
+9,137
+25% +$1.32M 0.02% 917
2014
Q2
$4.55M Buy
36,883
+6,946
+23% +$768K 0.01% 1277
2014
Q1
$3.1M Buy
29,937
+2,140
+8% +$219K 0.01% 1583
2013
Q4
$2.5M Sell
27,797
-4,284
-13% -$342K 0.01% 1813
2013
Q3
$2.15M Buy
32,081
+3,049
+11% +$210K 0.01% 1874
2013
Q2
$1.92M Buy
+29,032
New +$1.66M 0.01% 1854

Other funds holding SLXP

Parametric Portfolio Associates's SLXP Position: Q2 2015 in Review

Parametric Portfolio Associates sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 38,005 shares — an estimated $6.57M sold.

Parametric Portfolio Associates first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $7.19M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Parametric Portfolio Associates reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Parametric Portfolio Associates sold 38,005 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $6.57M.
  • Parametric Portfolio Associates first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Parametric Portfolio Associates's SALIX PHARMACEUTICALS LTD DEL position peaked at $7.19M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Parametric Portfolio Associates's 13F filing for Q2 2015, filed 14 Aug 2015.